SPTX

Seaport Therapeutics, Inc.

Healthcare · Biotechnology

$256.49 sample

-1.76 (-0.68%) 1D

Market cap

$924.4B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-10

Alerts

8

Price$256.49 +13.99% 3M daily closessample

260.98225.02

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider sell: 10% owner
Sep 16INSInsider sell: Chief Executive Officer
Sep 07INSInsider buy: 10% owner
Aug 27INSInsider sell: Director
Aug 19INSInsider buy: Chief Financial Officer
Aug 13INSInsider sell: General Counsel
Aug 10SECDEF 14A filed
Jul 30SEC10-Q filed

Sign up to see the real SPTX record →

Company facts

SEC EDGAR registration

Name: Seaport Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -11sample, -100 to +100
Reporting currency: USD

Who is positioning in SPTX

sample

Insiders: 19 insider transactions over 90 days, net selling, $113.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 5 funds hold $20.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.7B +22.8% y/y

Q4 2024Q3 2026

Inventory$20.7B +16.8% y/y

Q4 2024Q3 2026

Accounts receivable$16.2B +20.4% y/y

Q4 2024Q3 2026

Total debt$41.9B +14.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $491.7B -6.6% 3M
Sample peer B: $740.6B -6.8% 3M
Sample peer C: $478.9B -2.7% 3M
Sample peer D: $846.1B -1.7% 3M
Sample peer E: $527.9B +16.3% 3M